2 hours ago
Novo Nordisk (NVO) Stock Rises After Pediatric Diabetes Drug Trial Success
Novo Nordisk (NVO) stock gains after oral semaglutide pill succeeds in pediatric type 2 diabetes trial. Company targets H2 2026 filing for approval.
The post Novo Nordisk (NVO) Stock Rises After Pediatric Diabetes Drug Trial Success appeared first on Blockonomi.
Source: Blockonomi →Related News
- 7 minutes ago
Warner Bros Discovery (WBD) Stock: Paramount’s $81B Acquisition Gets Shareholder...
- 8 minutes ago
Western Digital (WDC) Stock Soars 936% to Record High on Earnings Beat and Analy...
- 21 minutes ago
Moog (MOG.A) Q2 Earnings Report: Can Momentum Continue After Record-Breaking Q1?
- 22 minutes ago
Lululemon (LULU) Shares Plunge 12% Following New CEO Appointment
- 28 minutes ago
Avis Budget (CAR) Stock Plunges 40% as Dramatic Short Squeeze Unravels